Ischemic heart disease Board decisions

The veteran withdrew his appeals for earlier effective dates and increased ratings, resulting in the dismissal of all claims.

The Board remands the issue of entitlement to a rating higher than 30 percent for AHD prior to January 15, 2021, to correct pre-decisional duty to assist errors.

The Board denied service connection for a heart condition due to the lack of evidence showing a current diagnosis or residuals, and remanded claims for hypertension and prostate cancer for further development.

The Board remands the claims for service connection and special monthly compensation due to a pre-decisional duty to assist error, specifically related to toxic exposure risk activities under the PACT Act.

The Board granted service connection for coronary artery disease, hypertension, and stroke based on the Veteran's exposure to diesel fuel during active duty.

The Board denied an increased disability rating for Meniere's disease and remanded the service connection claims for heart, essential tremors, brain, and diverticulosis disabilities.

The Board remands the claims for service connection for ischemic heart disease, cardiomyopathy, a prostate disorder, diabetes mellitus, and hypertension to obtain additional evidence regarding toxic exposure risk activities during the Veteran's service.

The Board denied service connection for a heart disability, to include ischemic heart disease and aortic valve disease with aortic valve replacement, as the evidence did not support a finding that these conditions began during active service or are otherwise related to an in-service injury or disease.

The Board granted service connection for an acquired psychiatric disorder, but remanded the claims for a heart disability and bilateral restless leg syndrome.

The Board granted service connection for hypertensive vascular disease (claimed as a heart disorder) based on the Veteran's participation in toxic exposure risk activities during his military service.

The Board denied service connection for diabetes mellitus, type II, a skin disorder, and a heart disorder as the evidence did not support a finding that these conditions were related to the Veteran's active military service.

The Board remands the claims for service connection for various disabilities, including a heart disorder, neck artery disability, leg bypass surgery and residuals thereof, kidney transplant and residuals thereof, and left to right leg artery transplant and residuals thereof, as there has not been substantial compliance with previous remand directives.

The Board denied service connection for hypertension, a heart disorder, and erectile dysfunction as the evidence did not support a causal relationship between these conditions and the Veteran's military service.

The Board denied service connection for coronary artery disease, hypertension, a seizure disability, peripheral vascular disease, chronic kidney disease, and diabetes mellitus as the record does not show that these conditions were incurred in or caused by service.

The Board remands the claims for service connection for coronary artery disease with congestive heart failure and hypertension, to include as due to herbicide agent exposure, for further development of the record.

The Board denied an initial compensable rating for bilateral hearing loss and remanded the claims for service connection for diabetes mellitus Type II, hypertension, and coronary artery disease.

The Board denied higher staged ratings for ischemic heart disease, hypertension, and PTSD but granted a total disability rating based on individual unemployability (TDIU) from August 1, 2022.

The Board granted service connection for coronary artery disease and diabetes mellitus, type 2 due to the Veteran's exposure to herbicide agents during his service in Korea. The claim for a brain tumor was remanded for further development.

The Board denied the claims for earlier effective dates, service connection for various conditions, and remanded some issues for further development.

The Board denied service connection for hypertension and remanded the claim for heart disease, to include non-ischemic cardiomyopathy.